CGH
AGN

Crossmark Global Holdings’s Allergan plc AGN Stock Holding History

Crossmark Global Holdings’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,263
Closed -$2.88M – 1392
2020
Q1 		$2.88M Buy
16,263
+128
+0.8% +$24.1K 0.1% 225
2019
Q4 		$3.08M Sell
16,135
-6,696
-29% -$1.21M 0.08% 261
2019
Q3 		$3.84M Sell
22,831
-1,366
-6% -$223K 0.11% 215
2019
Q2 		$4.05M Buy
24,197
+637
+3% +$88.2K 0.11% 216
2019
Q1 		$3.45M Sell
23,560
-1,107
-4% -$160K 0.1% 242
2018
Q4 		$3.3M Buy
24,667
+6,028
+32% +$988K 0.1% 239
2018
Q3 		$3.55M Sell
18,639
-984
-5% -$181K 0.09% 263
2018
Q2 		$3.27M Sell
19,623
-1,136
-5% -$182K 0.09% 260
2018
Q1 		$3.49M Sell
20,759
-1,225
-6% -$205K 0.09% 271
2017
Q4 		$3.6M Buy
21,984
+868
+4% +$156K 0.09% 282
2017
Q3 		$4.33M Buy
+21,116
New +$4.91M 0.11% 223
2016
Q3 		$4.33M Buy
+21,116
New +$5.16M 0.11% 223

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Crossmark Global Holdings's AGN Position: Q2 2020 in Review

Crossmark Global Holdings sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 16,263 shares — an estimated $2.88M sold.

Crossmark Global Holdings first reported a position in AGN in Q3 2016 and held it in 12 quarters. The position peaked at $4.33M in Q3 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Crossmark Global Holdings reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Crossmark Global Holdings sold 16,263 Allergan plc shares in Q2 2020, an estimated $2.88M.
  • Crossmark Global Holdings first reported a position in Allergan plc in Q3 2016 and held it in 12 quarters.
  • Crossmark Global Holdings's Allergan plc position peaked at $4.33M in Q3 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Crossmark Global Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.